The U.S. Food and Drug Administration Friday granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse...

Prescribing prolonged courses of antibiotics for patients experiencing symptoms attributed to Lyme disease can lead to harmful health outcomes, says a new position paper by Canada’s infectious disease...

The United States faces a converging public health crisis as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin...

A new strategy to combat antibiotic resistance has emerged from a study led by researchers at Baylor College of Medicine. Published in the journal Molecular Cell, the report reveals for the first time...

CDC is issuing new guidance to clinicians for the treatment of severe malaria cases in the United States (U.S.). This change in treatment protocol is necessary because the only FDA-approved intravenous...

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting...

Chili’s and Maggiano’s parent company Brinker International has updated its animal welfare standards to include a commitment to working toward elimination of the use of medically important antibiotics...

An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat...

Antibiotic resistance is spreading from wastewater treatment plants The products of wastewater treatment have been found to contain trace amounts of antibiotic resistant DNA. These products are often...

The US Food and Drug Administration (FDA) issued a safety alert today concerning the dosing of the rheumatoid arthritis (RA) drug, Xeljanz and Xeljanz XR. A safety clinical trial found an increased risk...